In Stock

TiterSafe Influenza A (H3N2), Thailand/8/2022

SKU:
HAP-1216
Maximum Purchase:
10 units
Current Stock:
Virus (Subtype):
Influenza A (H3N2)
Strain:
Thailand/8/2022
Unit:
200µL
Lead Time:
1-4 weeks
$755.00
Request a quote, including discounts on bulk orders
HA assay was performed using 1% Guinea Pig RBCs in a 96-well plate. The HA assay was used to determine an Influenza A TiterSafe titer at 4 HA units. The titer at 4 HA units and hyperimmune serum were used to perform the HAI assay. Reported serum dilutions are defined prior to TiterSafe volume addition.
TiterSafe by Integral Molecular, Inc.

Frequently Bought Together:

HA assay was performed using 1% Guinea Pig RBCs in a 96-well plate. The HA assay was used to determine an Influenza A TiterSafe titer at 4 HA units. The titer at 4 HA units and hyperimmune serum were used to perform the HAI assay. Reported serum dilutions are defined prior to TiterSafe volume addition.
Inc. Tax
Ex. Tax

Influenza TiterSafe, an HAI reagent, consists of non-replicative virus-like particles (VLPs) that display influenza HA and NA on a lentivirus core. TiterSafe replaces live virus in the hemagglutination inhibition assay (HAI), the standard assay for testing immune sera to determine to assess serum antibody titers. Protocols are provided for HA and HAI assays, with guinea pig RBCs the recommended target.

Product TiterSafe Hemagglutinating Particles, Influenza A
Catalog Number HAP-1216
Subtype H3N2
Strain Thailand/8/2022
Expected Dilution to 4HA units 1:128
Red Blood Cells (Not Included) Guinea Pig RBCs
Lead time 1-4 weeks
Shipping Shipped on dry ice
Storage conditions Store at ≤ -80°C upon receipt
Size 200µL/vial
Packaging DMEM

Related Products